Dr Catherine Hurd

Catherine is a Postdoctoral Research Associate working as part of the GSK/Crick Linklabs collaboration. Her current work focuses on the development of cyclic peptide tools for target validation. Prior to working at GSK, Catherine completed her PhD at the University of Cambridge (Department of Biochemistry) with Dr Darerca Owen and Dr Helen Mott. For her PhD project, Catherine developed stapled peptide inhibitors of the Ral GTPases.